Related Experiment Video
Updated: Jan 6, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53
Yajie Chen1,2,3, Qian Hao1,3, Jieqiong Wang1,3
1Cancer Institute, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, China.
Abstract:
Hotspot p53 mutants augment cancer cell proliferation, metastasis and metabolism through their gain-of-function (GOF). Ovarian cancer sustains the highest frequency of TP53 mutations, but the mechanisms underlying regulation of mutant p53s' GOF in this type of cancer remain incompletely understood. Herein, we identified the E3-ubiquitin ligase TRIM71 as a novel mutant p53-binding protein. Ectopic TRIM71-induced ubiquitination and proteasomal degradation of mutant p53 by binding to its transactivation (TA) domain, and inhibited the expression of a broad spectrum of mutant p53 target genes. Ectopic TRIM71 also restrained, whereas ablation of TRIM71 endorsed, ovarian carcinoma cell growth in vitro and in vivo. Significantly, TRIM71 overexpression is highly associated with favorable prognosis, particularly, in TP53-mutated ovarian carcinomas. Altogether, our findings unveil the anti-tumor function of TRIM71 in ovarian cancer development and prognosis by downregulating mutant p53s.
Insights
Researchers found TRIM71, an E3-ubiquitin ligase, targets mutant p53 in ovarian cancer. TRIM71 reduces tumor growth and is linked to better patient outcomes, revealing its anti-cancer role.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Hotspot p53 mutants promote cancer progression via gain-of-function (GOF).
- Ovarian cancer frequently harbors TP53 mutations, yet regulation of mutant p53 GOF is not fully understood.
Purpose of the Study:
- To identify novel regulators of mutant p53 gain-of-function in ovarian cancer.
- To investigate the role of TRIM71 in mutant p53 regulation and ovarian cancer progression.
Main Methods:
- Identified TRIM71 as a direct binding partner of mutant p53.
- Demonstrated TRIM71-induced ubiquitination and proteasomal degradation of mutant p53.
- Assessed the impact of TRIM71 modulation on ovarian carcinoma cell growth in vitro and in vivo.
Main Results:
- TRIM71 binds to the transactivation domain of mutant p53, promoting its degradation.
- Ectopic TRIM71 expression inhibited ovarian carcinoma cell proliferation and tumor growth.
- TRIM71 ablation accelerated tumor progression.
- TRIM71 overexpression correlated with favorable prognosis in TP53-mutated ovarian cancers.
Conclusions:
- TRIM71 functions as an anti-tumor factor in ovarian cancer by downregulating mutant p53.
- TRIM71 represents a potential therapeutic target for improving prognosis in TP53-mutated ovarian cancers.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
The Unfolded Protein Response
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

